Furthermore, the bone ECM provides a supportive niche for osteosarcoma metastasis, where elevated LOXL2 expression contributes to increased matrix stiffness and enhanced cell-matrix adhesion 41. This evidence concerns the gene LOXL2 and osteosarcoma.